news

Feb 10 2016
FDA Grants Priority Review to KemPharm for KP201/APAP NDA

Feb 9 2016
KemPharm Announces Closing of $86.25 Million 5.50% Senior Convertible Notes Due 2021

Feb 9 2016
Aytu BioScience Announces First Commercial Sales for Company's MiOXSYS™ System for Male Infertility


 

events

Feb 8-9 2016
BIO CEO & Investor Conference

Feb 10-11 2016
Leerink Partners Global Healthcare Conference

Feb 23 2016
Sachs 4th Annual Cancer BioPartnering & Investment Forum

Feb 29-Mar 4 2016
HIMSS16

Mar 11 2016
Future Leaders in the Biotech Industry


 

spotlight